Trial intelligence / Profile preview

Platelet preservation with bivalirudin versus heparin during intraoperative autologous blood donation in cardiac surgery

NL-OMON31386Not yet recruiting

Sponsor
University Medical Center Groningen
Start
Sep 2007
Modality
Small Molecules, Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Open-label trial of bivalirudin and heparin in perioperative bleeding (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: In vitro platelet function during cardiopulmonary bypass and Post-bypass blood loss and clot quality. Planned start Sep 2007; status: not yet recruiting.

02

Drugs

bivalirudinheparin
03

Conditions

perioperative bleeding

Beyond the preview

Go deeper on NL-OMON31386.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON31386.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call